A Phase 2 study of pemetrexed and carboplatin for platinum-pretreated patients with non small cell lung cancer
Phase 2
- Conditions
- platinum pretreated patients with non small cell lung cancer
- Registration Number
- JPRN-UMIN000005552
- Lead Sponsor
- Osaka Prefectural Medical Center for Respiratory and Allergic deseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criterias are as follows 1: Active interstitial pneumonia identified by chest X-ray 2: Uncontrolled massive pleural effusion or cardiac effusion 3: Superior vena cava syndrome 4: Uncontrolled brain metastases 5: Uncontrolled diabetes mellitus, hypertension, hepatic disorder, angina pectoris or previous myocardial infarction within the last 12 months 6: Severe infection 7: Pregnancy or lactation 8: Active concomitant malignancy 9: History of severe allergic reactions to drugs 11: Severe and unstable medical 10morbidities 11: Judgment to attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy
- Secondary Outcome Measures
Name Time Method safety,OS,PFS